Brimonidine Tartate 0.2% 5mL

NDC: 24208-411-05

Brimonidine Tartrate 0.2% Ophthalmic Solution, 5 mL — Bausch & Lomb

Active ingredient	Brimonidine tartrate 0.2%
Dosage form	Ophthalmic solution
Route	Topical ophthalmic
Size	5 mL
Manufacturer	Bausch & Lomb
NDC	24208-411-05

Indications and Usage

Indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Dosage and Administration

Instill one drop in the affected eye(s) three times daily, approximately 8 hours apart. If more than one topical ophthalmic product is used, separate instillations by at least 5 minutes.

Warnings and Precautions

• May cause fatigue and drowsiness; use caution when driving or operating machinery
• Use caution in patients with severe cardiovascular disease, cerebral or coronary insufficiency, orthostatic hypotension, depression, or Raynaud's phenomenon
• Benzalkonium chloride may be absorbed by soft contact lenses; wait 15 minutes before reinserting lenses

Contraindications

Contraindicated in neonates and infants under 2 years of age and in patients with known hypersensitivity to any component.

Adverse Reactions

Common effects (10 to 30%) include oral dryness, ocular hyperemia, burning and stinging, headache, blurred vision, foreign body sensation, and fatigue or drowsiness.

Storage and Handling

Store at 15°C to 25°C (59°F to 77°F).

How Supplied

Supplied sterile as a 5 mL solution in a plastic bottle with a purple cap.

Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.

If you have any questions related to DSCSA compliance, transaction history, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com for more information.